Simon Ducharme, MD, MSc, FRCP(C)

Contact
simon.ducharme@mcgill.ca
6875 Boulevard LaSalle Montréal, QC H4H 1R3
ORCID iD: https://orcid.org/0000-0002-7309-1113
Researcher, Douglas Research Centre
Associate Professor, Department of Psychiatry, McGill University
Clinical Research Scholar, Fonds de recherche du Québec – Santé (FRQS), Senior
Lab name: FTD & Neuropsychiatry Lab
Theme-Based Group: Aging, Cognition, and Alzheimer’s DiseaseDivision: Clinical Research
The FTD & Neuropsychiatry Lab led by Dr. Simon Ducharme aims to develop clinical and therapeutic tools for neuropsychiatric disorders, focusing on major neurocognitive disorders. We are conducting translational studies using structural and functional imaging in frontotemporal dementia (FTD) to improve early diagnostic markers for this devastating disease. Our group is involved in several national and international neuroimaging studies on dementia, in addition to innovative clinical trials on Alzheimer’s disease and FTD.
Dr. Simon Ducharme has a medical degree from the Université de Montréal and a Masters from McGill University. He completed his residency in Psychiatry at McGill in 2012, and a fellowship in Behavioral Neurology and Neuropsychiatry at Harvard University in 2014.
He has a board certification in Behavioral Neurology and Neuropsychiatry from the United Council for Neurological Subspecialties. He currently works as a Neuropsychiatrist at the Douglas Mental Health Institute. He has a clinical specialty in frontotemporal dementia.
Dr. Ducharme has received over 35 awards of academic or research excellence, including the 2013 Career Development Award from the American Neuropsychiatric Association and is an FRQS-funded clinician-scientist.
His research uses advanced structural brain-imaging techniques to study the longitudinal changes in brain development from childhood to old age, and how it impacts behaviour across health and psychopathology. His current projects aim to develop novel neuroimaging diagnostic and prognostic biomarkers for frontotemporal dementia.
He is the Montreal site PI of the Genetic Frontotemporal Dementia Initiative study and the FTD team leader of the Canadian Consortium on Neurodegeneration in Aging. He is the current chair of the American Neuropsychiatric Association committee on research. Dr. Ducharme is in charge of several clinical trials for Alzheimer’s disease and related dementia.
![]() | David Benrimoh, MD | Graduate Student |
![]() | Tristin Best, MSc | Graduate Student, IPN program |
![]() | Simon Ducharme, MD, MSc, FRCP(C) | Principal Investigator |
![]() | Jake Levy, MD | Graduate Student |
![]() | Ana Manera, MD | Post-Doctoral Fellow |
![]() | Jillian McCarthy, BSc | Graduate Student |
![]() | Mahdie Soltaninejad | Graduate Student, IPN program |
![]() | Teodora Yaneva, MSc | Research Staff |
Key publications
Liste complète des publications.
- Manera AL, Dadar M, Collins DL, Ducharme S; Frontotemporal Lobar Degeneration Neuroimaging Initiative. Deformation based morphometry study of longitudinal MRI changes in behavioral variant frontotemporal dementia. Neuroimage Clin. 2019;24:102079. doi: 10.1016/j.nicl.2019.102079. Epub 2019 Nov 5. Pubmed PMID: 31795051.
- Ducharme S, Pearl-Dowler L, Gossink F, McCarthy J, Lai J, Dickerson BC, Chertkow H, Rapin L, Vijverberg E, Krudop W, Dols A, Pijnenburg Y. The Frontotemporal Dementia versus Primary Psychiatric Disorder (FTD versus PPD) Checklist: A Bedside Clinical Tool to Identify Behavioral Variant FTD in Patients with Late-Onset Behavioral Changes. J Alzheimers Dis. 2019;67(1):113-124. PubMed PMID: 30584146.
- Levy JP, Bocti C, Elie D, Paquet N, Soucy JP, Ducharme S. Bifrontal Hypermetabolism on Brain FDG-PET in a Case of C9orf72-Related Behavioral Variant of Frontotemporal Dementia. J Neuropsychiatry Clin Neurosci. 2019 Winter;31(1):92-94. PubMed PMID: 30404533.
- Benrimoh D, Pomerleau VJ, Demoustier A, Poulin S, Maltais JR, Brouillette J, Ducharme S. Why We Still Use “Organic Causes”: Results From a Survey of Psychiatrists and Residents. J Neuropsychiatry Clin Neurosci. 2019 Winter;31(1):57-64. PubMed PMID: 30305004.
- Alhusaini S, Karama S, Nguyen TV, Thiel A, Bernhardt BC, Cox SR, Corley J, Taylor A, Evans AC, Star JM, Bastin ME, Wardlaw JM, Deary IJ, Ducharme S. Association between carotid atheroma and cerebral cortex structure at age 73 years. Ann Neurol. 2018 Oct;84(4):576-587. PubMed PMID: 30179274.
- McCarthy J, Collins DL, Ducharme S. Morphometric MRI as a diagnostic biomarker of frontotemporal dementia: A systematic review to determine clinical applicability. Neuroimage Clin. 2018;20:685-696. PubMed PMID: 30218900.
- Ducharme S, Price BH, Dickerson BC. Apathy: a neurocircuitry model based on frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):389-396. PubMed PMID: 29066518.
- Ducharme S, Bajestan S, Dickerson BC, Voon V. Psychiatric Presentations of C9orf72 Mutation: What Are the Diagnostic Implications for Clinicians? J Neuropsychiatry Clin Neurosci. 2017 Summer;29(3):195-205. PubMed PMID: 28238272.
- Ducharme S, Albaugh MD, Nguyen TV, Hudziak JJ, Mateos-Pérez JM, Labbe A, Evans AC, Karama S. Trajectories of cortical thickness maturation in normal brain development–The importance of quality control procedures. Neuroimage. 2016 Jan 15;125:267-279. PubMed PMID: 26463175.
- Ducharme S, Murray ED, Seiner SJ, Tayeb H, Legesse B, Price BH. Retrospective Analysis of the Short-Term Safety of ECT in Patients With Neurological Comorbidities: A Guide for Pre-ECT Neurological Evaluations. J Neuropsychiatry Clin Neurosci. 2015 Fall;27(4):311-21. PubMed PMID: 25658682.
- Ducharme S, Price BH, Larvie M, Dougherty DD, Dickerson BC. Clinical Approach to the Differential Diagnosis Between Behavioral Variant Frontotemporal Dementia and Primary Psychiatric Disorders. Am J Psychiatry. 2015 Sep 1;172(9):827-37. PubMed PMID: 26324301.
- Ducharme S, Dickerson BC. The neuropsychiatric examination of the young-onset dementias. Psychiatr Clin North Am. 2015 Jun;38(2):249-64. PubMed PMID: 25998114.
- Karama S, Ducharme S, Corley J, Chouinard-Decorte F, Starr JM, Wardlaw JM, Bastin ME, Deary IJ. Cigarette smoking and thinning of the brain’s cortex. Mol Psychiatry. 2015 Jun;20(6):778-85. PubMed PMID: 25666755.
- Ducharme S, Albaugh MD, Hudziak JJ, Botteron KN, Nguyen TV, Truong C, Evans AC, Karama S. Anxious/depressed symptoms are linked to right ventromedial prefrontal cortical thickness maturation in healthy children and young adults. Cereb Cortex. 2014 Nov;24(11):2941-50. PubMed PMID: 23749874.
- Ducharme S, Guiot MC, Nikelski J, Chertkow H. Does a positive Pittsburgh Compound B scan in a patient with dementia equal Alzheimer disease?. JAMA Neurol. 2013 Jul;70(7):912-4. PubMed PMID: 23689280.
- Ducharme S, Hudziak JJ, Botteron KN, Albaugh MD, Nguyen TV, Karama S, Evans AC. Decreased regional cortical thickness and thinning rate are associated with inattention symptoms in healthy children. J Am Acad Child Adolesc Psychiatry. 2012 Jan;51(1):18-27 PubMed PMID: 22176936.
- Le Blanc G, Jetté Pomerleau V, McCarthy J, Borroni B, van Swieten J, Galimberti D, Sanchez-Valle R, LaForce R Jr, Moreno F, Synofzik M, Graff C, Masellis M, Tartaglia MC, Rowe JB, Vandenberghe R, Finger E, Tagliavini F, de Mendonça A, Santana I, Butler C, Gerhard A, Danek A, Levin J, Otto M, Frisoni G, Sorbi S, Rohrer JD, Ducharme S; Genetic Frontotemporal Dementia Initiative (GENFI). Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers. Ann Neurol. 2020 Jul;88(1):113-122
- Ducharme S, Dols A, Laforce Jr R, Devenney E, Kumfor F, van den Stock J, Dallaire-Théroux C, Seelaar H, Gossink F, Vijverberg E, Huey E, Vandenbuicke M, Masellis M, Trieu C, Onyike C, Caramelli P, de Souza L, Santillo A, Landqvist Waldö M, Landin-Romero R, Piguet O, Kelso W, Eratne D, Velakouli D, Ikeda M, Perry D, Pressman P, Boeve B, Vandenberghe, R, Mendez M, Azuar C, Levy R, Le Ber I, Baez S, Lerner A, Ellajosyula R, Pasquier F, Galimberti D, Scarpini E, van Swieten J, Hornberger M, Rosen H, Hodges J, Diehl-Schmid J, Pijnenburg Y. Recommendations to Distinguish Behavioural Variant Frontotemporal Dementia from Psychiatric Disorders. Brain. 2020 Jun 1;143(6):1632-1650.
Publications
2021
Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study Journal Article
In: Alzheimers Dement (Amst), vol. 13, no. 1, pp. e12185, 2021, ISSN: 2352-8729.
2019
Age-specific associations between oestradiol, cortico-amygdalar structural covariance, and verbal and spatial skills Journal Article
In: J Neuroendocrinol, vol. 31, no. 4, pp. e12698, 2019, ISSN: 1365-2826.
2018
Association between carotid atheroma and cerebral cortex structure at age 73 years Journal Article
In: Ann Neurol, vol. 84, no. 4, pp. 576–587, 2018, ISSN: 1531-8249.
News
Drs. El Mestikawy and Ducharme obtain CQDM funding for two collaborative projects
June 18, 2026 We are pleased to announce that CQDM is funding two projects run by Douglas researchers, Drs. Simon Ducharme and Salah El Mestikawy. Their two projects are among six collaborative R&D projects supported by CQDM and that collectively represent a total investment of $10,173,321. Supported by $3,908,482 from the Government of Québec and…
Dr. Simon Ducharme featured in ‘Découverte’
Dr. Simon Ducharme is featured in the latest episode of the documentary Découverte, broadcast on Radio-Canada. Alzheimer’s: the arrival of innovative drugsNew drugs designed to slow the progression of Alzheimer’s disease are coming onto the market. This initial hope, however, gives way to disappointment upon closer examination. Our healthcare systems may not be ready to…
Douglas Candidates Awarded CIHR Postdoctoral Research Award
April 8, 2026 We are pleased to present the list of Douglas Research Centre trainees who have been awarded CIHR Postdoctoral Research Awards. The Canada Postdoctoral Research Award (CPRA) program recognizes and supports the next generation of outstanding innovators, knowledge workers, creative thinkers and researchers at a pivotal time in their careers. The program provides…
AI in mental health: between risks and innovation – Dr. Ducharme
In an article published on Radio-Canada Info, Dr. Simon Ducharme discusses the growing role of artificial intelligence in mental health and psychiatric research. The article explores both the risks and potential of conversational agents in mental health, as well as the innovations made possible by AI. Dr. Ducharme presents the SPARK biobank project, which aims…
A promising biomarker to distinguish dementia from mental disorders
December 7, 2025 — FRQS Impact Story The work led by Dr. Simon Ducharme was featured in an impact story on the Fonds de recherche du Québec (FRQS) website, highlighting the clinical and societal significance of these studies. Dr. Ducharme and his team are working to improve the distinction between the earliest signs of a…
Health Canada approves drug to slow Alzheimer’s disease – Dr Ducharme
Health Canada has just approved lecanemab, a drug already authorised in several other countries for the treatment of Alzheimer’s disease. This treatment could delay the onset of symptoms by about a year in people at risk. In a television report on Le Téléjournal (Radio-Canada), Dr Ducharme shares his expertise on this new treatment and its…
Fighting Alzheimer’s disease: Scientific debate over new treatments – Dr Simon Ducharme
Dr. Simon Ducharmetook part in an interview published in La Presse about new Alzheimer’s disease treatments, including lecanemab.The article presents a debate among specialists about the benefits and risks of these emerging therapies. “The long-term data are encouraging: over four years, we’ve extended autonomy by one year.“ — Dr. Simon Ducharme
Caring for someone with dementia: What you need to know about hallucinations, delusions and paranoia – Dr. Simon Ducharme
In this episode of McGill Cares, a series of webcasts to support informal carers, Dr. Simon Ducharme explains how dementia can lead to hallucinations, delusions and paranoia. He details their impact on the person with dementia and their loved ones, and offers practical strategies for better managing these situations, as well as advice on when to…
Trainee award winners at Research Day 2025
The Douglas Research Centre and the Department of Psychiatry of McGill University held their annual Research Day on Thursday, June 19, 2025. As every year, the participation and contribution of many trainees, researchers and volunteers ensured the success of this event! Many short and long oral presentations were given throughout the day, as well as…
Announcement of 2025 Dr. Holly Carsley Memorial Award and 2025 Dr. Rémi Quirion Award of Excellence recipients
We are pleased to announce the winners of the Carsley and Quirion Awards! 2025 Dr. Holly Carsley Memorial Award Two prizes were awarded : Sophie Simard (Dr. Naguib Mechawar team) Sierra Codeluppi (Dr. Gustavo Turecki team) 2025 Dr Rémi Quirion Award of Excellence This award…







